A-M-R
☆    

Egypt,
2014-10-12 13:14
(3921 d 07:44 ago)

Posting: # 13690
Views: 3,747
 

 Rosuvastatin BE study [Dissolution / BCS / IVIVC]

Results of comparative dissolution were at pH = 29 (failed), at pH 4.5 = 58 and at pH 6.8 = 57 so advice me if I can start clinical part of BE study based on above results of comparative dissolution and appropriate design of study to decrease difference.
very thanks
Amr hussein


Edit: Category changed. [Helmut]
UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,684 registered users;
86 visitors (0 registered, 86 guests [including 12 identified bots]).
Forum time: 20:59 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5